Abstract:Fcγ receptors (FcÎ³R) have been proposed to be involved in the pathogenesis of acute rejection (AR) after organ transplantation. However, the mechanisms by which FcγRIIIB mediate this process are still unclear. Previous studies suggested that the FCGR3B gene copy number variation (CNV) is associated with the risk of autoimmune diseases. In this study, we delineated the association of FCGR3B-CNV with end-stage renal disease (ESRD) and risk of rejection post kidney transplantation in 414 kidney transplant recipients and 219 healthy subjects. Our data showed that the percentage of kidney transplant recipients with high copy number of FCGR3B gene was significantly lower than that of healthy controls, suggesting that individuals with low copy of FCGR3B gene are more prone to develop ESRD. Besides, patients with low copy of the FCGR3B gene are associated with susceptibility to AR following kidney transplantation. In mice, transgenic expression of human FcγRIIIB effectively inhibited the AR and improved the function of the transplanted kidney in a model of allogeneic kidney transplantation. This protective effect was associated with an inhibition of T lymphocytes infiltration and Th1 cell immune response. Finally, we showed that FcγRIIIB cross-linking combined with TNF-α treatment in vitro promoted neutrophil apoptosis and was associated with increased activation of cleaved caspase-8 and caspase-3. The combined treatment also increased the arginase-1 expression in neutrophils, which may explain FcγRIIIB-mediated immunosuppression.Funding: This work was supported by the National Fund Committee of China (2012CB517603, 2012AA02A512).Declaration of Interest: No conflicts of interest exist for any authors.Ethical Approval: The study was performed in adherence with the Declaration of Helsinki, and was approved by the Ethics Committee of the First Affiliated Hospital of College of Medicine of Zhejiang University. All patients and healthy controls provided written informed consent.

Elevated serum IL-21 levels are associated with stable immune status in kidney transplant recipients and a mouse model of kidney transplantation

Role of IL-18 in Transplant Biology

Role of IL-33 in Transplant Biology

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

leukin-15 (IL-15) production during acute rejection following heart transplantation in mice. Inbred male Balb/c (H-2d) and C57BL/6 (H-2b) mice were used to establish a heterotopic intra-abdominal cardiac transplantation model. The mice were divided in four groups: syngeneic control, allogeneic acute

Elevated number of IL-21+ TFH and CD86+CD38+ B cells in blood of renal transplant recipients with AMR under conventional immuno-suppression

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces De Novo Donor-Specific Antibody Generation

Role of IL-21 Signaling Pathway in Transplant-Related Biology.

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Clinical Implication of Monitoring Interleukin-18 Receptor on Peripheral Lymphocytes for Diagnosis and Treatment of Rejection after Renal Transplantation

FcγRIIIb Inhibits Renal Transplant Rejection by Inducing Neutrophils Apoptosis

Transduction of Interleukin-10 Through Renal Artery Attenuates Vascular Neointimal Proliferation and Infiltration of Immune Cells in Rat Renal Allograft.

Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients

Cxcl10 and Cxcl13 Expression Were Highly Up-Regulated in Peripheral Blood Mononuclear Cells in Acute Rejection and Poor Response to Anti-Rejection Therapy

[Significance of Sequential Monitoring of Serum IL-18 in Renal Allograft Recipients].

Increased Expression of Non-Interleukin-2 T Cell Growth Factors and Their Implications During Liver Allograft Rejection in Rats

Potential biomarkers for immune monitoring after renal transplantation

Retrospective Study of Detection of Serum IL-17 for Predicting Early Acute Renal Allograft Rejection by Luminex Technique